NINR Clinical Trial Planning Grant (R34 Clinical Trial Required) | PAR 19 060

Opportunity Information: Apply for PAR 19 060

The NINR Clinical Trial Planning Grant (R34 Clinical Trial Required), funding opportunity number PAR-19-060, is a discretionary NIH grant designed to give research teams dedicated time and resources to fully plan an investigator-initiated clinical trial that aligns closely with the mission of the National Institute of Nursing Research (NINR). The central aim is not to fund the full-scale clinical trial itself, but to support the work that needs to happen before a larger trial can responsibly launch, including refining the research questions, locking down key design decisions, and building the operational roadmap for how the trial will actually be carried out.

A defining expectation of this R34 is that the planning period includes feasibility and pilot work that directly informs whether the proposed intervention and trial approach are viable. In practice, that means award-supported activities should help answer real-world questions such as whether recruitment strategies will work, whether participants will accept and adhere to the intervention, whether study procedures are practical in the intended settings, and whether the measurement plan is workable and sensitive enough. These feasibility or pilot activities are intended to reduce risk and uncertainty before a larger, more expensive clinical trial is proposed, and to produce concrete evidence that the intervention and trial methods can be implemented as planned.

The opportunity is categorized under Education and Health and is administered by the National Institutes of Health under CFDA 93.361. It uses the grant funding instrument. The listed award ceiling is $150,000, indicating a modest budget consistent with planning, early testing, and trial-preparation tasks rather than full trial execution. The FOA record notes an original closing date of July 16, 2020, and a creation date of November 7, 2018, which situates it as an established NIH mechanism for trial planning within the NINR portfolio.

Eligibility is broad and includes a wide range of domestic organizations and several special categories that often align with community-based research and workforce development. Standard eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities and Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofits with or without 501(c)(3) status (outside of higher education); for-profit organizations other than small businesses; and small businesses. In addition, the FOA explicitly highlights other eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, Indian/Native American tribal governments other than federally recognized entities, and even non-domestic (non-U.S.) entities (foreign organizations). Taken together, this eligibility scope supports planning efforts that may involve academic medical centers, nursing schools, community organizations, tribal partners, and international collaborators when appropriate.

Overall, this FOA is best understood as a structured “trial-readiness” grant from NINR: it supports teams in doing the preparatory scientific and operational work needed to confidently move into a subsequent, fully powered clinical trial application. The required planning activities, especially feasibility and pilot studies, are meant to strengthen the rationale and execution plan so that the next-stage clinical trial is both methodologically sound and realistically implementable in the settings and populations the research intends to serve.

• The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NINR Clinical Trial Planning Grant (R34 Clinical Trial Required)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.361.
• This funding opportunity was created on 2018-11-07.
• Applicants must submit their applications by 2020-07-16. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $150,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 19 060

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: